Santen Pharmaceutical Co., Ltd.
4536
Classificação em ações
#4330
Santen Pharmaceutical Co., Ltd. is a global enterprise engaged in the research,... Santen Pharmaceutical Co., Ltd. is a global enterprise engaged in the research, development, manufacturing, and marketing of both pharmaceutical products and medical devices. The company's primary focus lies in ophthalmic solutions, addressing a variety of eye conditions. Its pipeline for glaucoma and ocular hypertension includes several key assets: DE-111, currently in Phase III clinical trials; DE-117, available for sale in Japan; DE-126, progressing through Phase IIb trials; DE-128, which is on the market in Europe and undergoing Phase II/III trials in the United States; and DE-130A, also in Phase III development. Beyond glaucoma, Santen's offerings extend to other ocular ailments. It provides DE-114A for allergic conjunctivitis and DE-076C for vernal keratoconjunctivitis. Furthermore, DE-109 is in Phase III clinical trials for the treatment of uveitis. The company is also active in addressing myopia with DE-127, currently in Phase II/III trials in Japan and Phase III in other Asian markets, alongside STN1013400, which is in Phase I trials. For dry eye, Santen offers DE-089C, which has successfully concluded its Phase III clinical trials. In addition to its prescription portfolio, the company produces and sells various over-the-counter (OTC) pharmaceutical products. Founded in 1890 under the name Santendo Pharmaceutical Co., Ltd., the company rebranded to its current name, Santen Pharmaceutical Co., Ltd., in 1958. It is headquartered in Osaka, Japan.
Preço da ação
$11.35
Última sincronização: 2026-10-16
Valor de mercado
$3.65B
Variação (1 dia)
1.55%
Variação (1 ano)
-0.91%
País
JP
Negociar Santen Pharmaceutical Co., Ltd. (4536)
Categoria
Healthcare
Capitalização de mercado de Santen Pharmaceutical Co., Ltd.(4536)
Valor de mercado: $3.65B
Em October 2026, Santen Pharmaceutical Co., Ltd. tem uma capitalização de mercado de $3.65B. Isso faz com que Santen Pharmaceutical Co., Ltd. seja a 4330th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Santen Pharmaceutical Co., Ltd. de 2010 a 2026
4536 comparado com o topo de 5 mais populares stocks
